Polydex Pharmaceuticals Stock Three Year Return
Polydex Pharmaceuticals fundamentals help investors to digest information that contributes to Polydex Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Polydex Pink Sheet. The fundamental analysis module provides a way to measure Polydex Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Polydex Pharmaceuticals pink sheet.
Polydex |
Polydex Pharmaceuticals Company Three Year Return Analysis
Polydex Pharmaceuticals' Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
CompetitionBased on the latest financial disclosure, Polydex Pharmaceuticals has a Three Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Polydex Three Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Polydex Pharmaceuticals' direct or indirect competition against its Three Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Polydex Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Polydex Pharmaceuticals by comparing valuation metrics of similar companies.Polydex Pharmaceuticals is currently under evaluation in three year return category among its peers.
Polydex Fundamentals
Return On Equity | -0.18 | |||
Return On Asset | -0.0824 | |||
Profit Margin | (0.25) % | |||
Operating Margin | (0.22) % | |||
Current Valuation | 2.23 M | |||
Shares Outstanding | 3.43 M | |||
Number Of Shares Shorted | 11 | |||
Price To Earning | 12.33 X | |||
Price To Book | 0.42 X | |||
Price To Sales | 0.51 X | |||
Revenue | 4.05 M | |||
Gross Profit | 970.3 K | |||
EBITDA | (568.16 K) | |||
Cash And Equivalents | 870.3 K | |||
Cash Per Share | 0.25 X | |||
Total Debt | 301.49 K | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 5.88 X | |||
Book Value Per Share | 1.44 X | |||
Cash Flow From Operations | (238.54 K) | |||
Short Ratio | 0.02 X | |||
Earnings Per Share | (0.13) X | |||
Number Of Employees | 21 | |||
Beta | 0.33 | |||
Market Capitalization | 2.23 M | |||
Total Asset | 6.56 M | |||
Retained Earnings | (19.53 M) | |||
Working Capital | 2.12 M | |||
Current Asset | 3.41 M | |||
Current Liabilities | 1.28 M | |||
Z Score | 1.4 |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Polydex Pink Sheet
If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |